SAR440234
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR440234, covering 2022-04-07 to 2022-04-07. Get the full timeline:
Most recent: Clinical Trial Update: First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome [Phase 1, Phase 2]